Link to National Cancer Institute Center for Cancer Research
Link to Contact CCRLink to CCR HomepageLink to NCI homeLink to NIH home
Technology Initiatives
Microarray
Clinical Proteomics
Biomedical Proteomics
Tissue Array
Research Program (TARP)
Animal Models
Bioinformatics
 
Microarray Technology

There are two microarray core resource facilities, one located at the Advanced Technology Center (ATC) in Gaithersburg headed by Dr. Ernie Kawasaki and one located in the Molecular Technology Lab in Frederick headed by Dr. David Munroe.

The mission of the Microarray Facility at the ATC is to:

  • manufacture quality cDNA microarrays for comprehensive gene expression analysis
  • provide training protocols and technical support to NCI researchers
  • develop new microarray technologies and applications

The Facility produces a human array of 9,000 genes. The synthesis of larger human arrays are being investigated utilizing new oligonucleotide technologies. Rat and mouse gene sequences are also being used in these studies. The ATC facility is also responsible for coordinating the use of high-density oligonucleotide arrays and instrumentation obtained from Affymetrix. The Affymetrix Genechip uses the draft human genome data to check the accuracy of sequences from public source databases, such as GenBank and RefSeq against the actual genome map. This cross checking of sequence information helps ensure high quality design data, helps in understanding gene relationships, and makes follow-up studies easier. There are more than 500,000 unique features on each chip. In addition discussions are ongoing with Agilent, Genspectra, and Motorola to explore additional microarray designs, printing techniques and informatics support.

The Laboratory of Molecular Technology (LMT, SAIC) is located at NCI-Frederick. The LMT is NCI's newest state-of-the-art gene discovery facility featuring high-throughput, cutting-edge genomics and analysis capabilities, including microarray services and technology development. The LMT Microarray Group coordinates their efforts with the ATC, and currently offers the Incyte GEM-2-based mouse array. New high-density mouse arrays are under development and will be available soon.

Microarray Steering Committee. Headed by Dr. Jeffrey Green, this steering committee will coordinate production of the gene microarrays currently being printed at both the ATC and at the LMT. The purpose is to facilitate the development of new array technologies, as well as the printing and distribution of microarrays to NCI researchers. Dr. Green will act as liaison between the Steering Committee, scientific investigators, ATC staff, and the LMT, to ensure implementation of programs and technologies that meet the needs of the scientific community. The Steering Committee plans to improve both the quality of the arrays and turnaround time, as well as explore new technologies.

Contacts:
Dr. Ernie Kawasaki at kawasake@mail.nih.gov
Dr. David Munroe at dm368n@nih.gov
Dr. Jeff Green at jg155c@nih.gov

Link to NIH
CCR Home | About CCR | Clinical Trials | Research | Employment
Featured Initiatives | News | Events | Site Privacy Policy
| Accessibility
Link to FirstGov